Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Serum Albumin  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC. "Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2009;53(4):596-605.
Folsom AR, Lutsey PL, Heckbert SR, Cushman M. "Serum albumin and risk of venous thromboembolism." Thromb Haemost. 2010;104(1):100-4.
Folsom AR, Ma J, Eckfeldt JH, Nieto FJ, Metcalf PA, Barnes RW. "Low serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima-media thickness. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Ann Epidemiol. 1995;5(3):186-91.
Franceschini N, van Rooij FJA, Prins BP, et al. "Discovery and fine mapping of serum protein loci through transethnic meta-analysis." Am J Hum Genet. 2012;91(4):744-53.
Kucharska-Newton AM, Couper DJ, Pankow JS, et al. "Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort." Arterioscler Thromb Vasc Biol. 2009;29(12):2182-90.
Parrinello CM, Matsushita K, Woodward M, Wagenknecht LE, Coresh JJ. "Risk prediction of major complications in individuals with diabetes: the Atherosclerosis Risk in Communities Study." Diabetes Obes Metab. 2016;18(9):899-906.
Parrinello CM, Sharrett ARichey, Maruthur NM, Bergenstal RM, Grams ME, Coresh JJ. "Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia." Diabetes Care. 2016;39(4):589-95.
Saito I, Folsom AR, Brancati FL, Duncan BB, Chambless LE, McGovern PG. "Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study." Ann Intern Med. 2000;133(2):81-91.
Selvin E, Francis LMA, Ballantyne CM, et al. "Nontraditional markers of glycemia: associations with microvascular conditions." Diabetes Care. 2011;34(4):960-7.
Selvin E, Rawlings AM, Lutsey PL, Maruthur N, Pankow JS, Steffes M. "Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death." Circulation. 2015;132(4):269-77.
Selvin E, Warren B, He X, Sacks DB. "Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol." Clin Chem. 2018;64(5):843-850.
Selvin E, Rawlings AM, Grams M, Klein R, Sharrett ARichey, Steffes M. "Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study." Lancet Diabetes Endocrinol. 2014;2(4):279-288.
Wattanakit K, Folsom AR, Chambless LE, Nieto JF. "Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study." Am Heart J. 2005;149(4):606-12.